Articles
First voluntary licensing of cancer drug sets ‘vital precedent’ for the industry
The first voluntary licence for a patented cancer medicine was signed last month on the fringes of the 2022 World Cancer Congress in Geneva. The agreement between the pharmaceutical company Novartis and…
